Saskia Middeldorp
@middeldorps.bsky.social
Head Department of Internal Medicine at Radboudumc, Nijmegen 🇳🇱. Professor fighting venous thromboembolism. Pregnancy, thrombosis, thrombophilia. Elected council member of ISTH. Feminist with ❤️ husband & 3 sons. 🚴🏼♀️🏃🏻♀️. #Hemesky #Thrombosky
Now my favourite topic presented eloquently by prof Marc Rodger.
Answering all the questions needed for providing well-informed information to your patients.
Put the #LMWH needles away in patients with placenta-mediated complications in inherited #thrombophilia!
#AFFIRM #ALIFE2
#ISTH2025
Answering all the questions needed for providing well-informed information to your patients.
Put the #LMWH needles away in patients with placenta-mediated complications in inherited #thrombophilia!
#AFFIRM #ALIFE2
#ISTH2025
June 25, 2025 at 1:44 PM
Now my favourite topic presented eloquently by prof Marc Rodger.
Answering all the questions needed for providing well-informed information to your patients.
Put the #LMWH needles away in patients with placenta-mediated complications in inherited #thrombophilia!
#AFFIRM #ALIFE2
#ISTH2025
Answering all the questions needed for providing well-informed information to your patients.
Put the #LMWH needles away in patients with placenta-mediated complications in inherited #thrombophilia!
#AFFIRM #ALIFE2
#ISTH2025
It took 7 years to recruit 51 patients for the IMPACT single-arm study on certiluzomab on top of LMWH-aspirin shows adverse outcome in 20% which is lower than non-contemporary controls.
#ISTH2025
#ISTH2025
June 25, 2025 at 1:25 PM
It took 7 years to recruit 51 patients for the IMPACT single-arm study on certiluzomab on top of LMWH-aspirin shows adverse outcome in 20% which is lower than non-contemporary controls.
#ISTH2025
#ISTH2025
There is more to established #thrombophilia defects in understanding the genetics of venous thromboembolism #VTE.
Plenary lecture by Prof Pierre Morange
#ISTH2025
Plenary lecture by Prof Pierre Morange
#ISTH2025
June 23, 2025 at 3:43 PM
There is more to established #thrombophilia defects in understanding the genetics of venous thromboembolism #VTE.
Plenary lecture by Prof Pierre Morange
#ISTH2025
Plenary lecture by Prof Pierre Morange
#ISTH2025
The effects of andexanet on enoxaparin are in line with effects on oral factorXa inhibitors.
Great presentation by PhD student Thijs van Haaps
#ISTH2025
Great presentation by PhD student Thijs van Haaps
#ISTH2025
June 23, 2025 at 1:58 PM
The effects of andexanet on enoxaparin are in line with effects on oral factorXa inhibitors.
Great presentation by PhD student Thijs van Haaps
#ISTH2025
Great presentation by PhD student Thijs van Haaps
#ISTH2025
June 23, 2025 at 1:09 PM
There is still taboo about discussing menstruation 🩸
There are differences between assessment of abnormal uterine bleeding between professional societies.
This is important to realisme and underscores the need to collaborate multidisciplinary.
Dr Roseline d’Oiron
#ISTH2025
There are differences between assessment of abnormal uterine bleeding between professional societies.
This is important to realisme and underscores the need to collaborate multidisciplinary.
Dr Roseline d’Oiron
#ISTH2025
June 23, 2025 at 12:52 PM
There is still taboo about discussing menstruation 🩸
There are differences between assessment of abnormal uterine bleeding between professional societies.
This is important to realisme and underscores the need to collaborate multidisciplinary.
Dr Roseline d’Oiron
#ISTH2025
There are differences between assessment of abnormal uterine bleeding between professional societies.
This is important to realisme and underscores the need to collaborate multidisciplinary.
Dr Roseline d’Oiron
#ISTH2025
Good morning everyone! Another exciting day ahead #ISTH2025.
Thirty years ago I visited my first @isth.org Congress.
📣 This morning, I can switch sessions to see two of my former PhD students shine in State-of-the-Art sessions.
We take good care of the next generation @isth.org!
Thirty years ago I visited my first @isth.org Congress.
📣 This morning, I can switch sessions to see two of my former PhD students shine in State-of-the-Art sessions.
We take good care of the next generation @isth.org!
June 23, 2025 at 11:32 AM
Interesting data on influence of race from the RIETE registry. After correction for treatment etc, these differences did not show in multi-variate analysis.
#ISTH2025
#ISTH2025
June 22, 2025 at 7:13 PM
Interesting data on influence of race from the RIETE registry. After correction for treatment etc, these differences did not show in multi-variate analysis.
#ISTH2025
#ISTH2025
This is what we were waiting for. A direct comparison between apixaban and rivaroxaban for the treatment of acute VTE. Apixaban reduces bleeding risk in the first 3 months by >50%!
Practice changing investigator-initiated RCT.
#ISTH2025
Practice changing investigator-initiated RCT.
#ISTH2025
June 22, 2025 at 1:49 PM
This is what we were waiting for. A direct comparison between apixaban and rivaroxaban for the treatment of acute VTE. Apixaban reduces bleeding risk in the first 3 months by >50%!
Practice changing investigator-initiated RCT.
#ISTH2025
Practice changing investigator-initiated RCT.
#ISTH2025
Intriguing findings from a high-quality prospective study on SVT in #pregnancy and #postpartum. Incident higher, heterogeneous treatment, but low rate of #DVT and #PE. I was surprised and so were the authors. Would love to see the full results.
#ISTH2025
#ISTH2025
June 21, 2025 at 6:13 PM
Intriguing findings from a high-quality prospective study on SVT in #pregnancy and #postpartum. Incident higher, heterogeneous treatment, but low rate of #DVT and #PE. I was surprised and so were the authors. Would love to see the full results.
#ISTH2025
#ISTH2025
Having fun and enjoying excellent science #ISTH2025 now on to my favourite topic #pregnancy and #thrombosis. Interesting cohort study on #LMWH - with therapeutic dose postpartum - still VTE. I think it could be a problem with adherence even though this was assessed by self-reporting
June 21, 2025 at 5:32 PM
Having fun and enjoying excellent science #ISTH2025 now on to my favourite topic #pregnancy and #thrombosis. Interesting cohort study on #LMWH - with therapeutic dose postpartum - still VTE. I think it could be a problem with adherence even though this was assessed by self-reporting
Great to be here! #ISTH2025. Looking forward to hearing and supporting all excellent science and scientists from all over the world. #thrombosis
June 20, 2025 at 5:34 PM
Great to be here! #ISTH2025. Looking forward to hearing and supporting all excellent science and scientists from all over the world. #thrombosis
I have been quiet on the socials for a while, but very excited to be on my way to @isth.org #ISTH2025 ✈️. Let's hope that Bluesky gets to fly too!
And I also just realized that it has been 30 years since my first @isth.org meeting in 1995. I haven't missed one single congress. #thrombosis
And I also just realized that it has been 30 years since my first @isth.org meeting in 1995. I haven't missed one single congress. #thrombosis
June 19, 2025 at 8:52 AM
I have been quiet on the socials for a while, but very excited to be on my way to @isth.org #ISTH2025 ✈️. Let's hope that Bluesky gets to fly too!
And I also just realized that it has been 30 years since my first @isth.org meeting in 1995. I haven't missed one single congress. #thrombosis
And I also just realized that it has been 30 years since my first @isth.org meeting in 1995. I haven't missed one single congress. #thrombosis
Large international multicenter cohort study showing that DOACs are a good option to treat cerebral venous thrombosis. Kudos to @jonathancoutinho20.bsky.social and team for pulling this off!
authors.elsevier.com/c/1ke765FFzL...
authors.elsevier.com/c/1ke765FFzL...
February 20, 2025 at 7:14 AM
Large international multicenter cohort study showing that DOACs are a good option to treat cerebral venous thrombosis. Kudos to @jonathancoutinho20.bsky.social and team for pulling this off!
authors.elsevier.com/c/1ke765FFzL...
authors.elsevier.com/c/1ke765FFzL...